Occupational zoonotic sporotrichosis with atypical evolution and refractory to treatment with itraconazole

Sporotrichosis is a neglected zoonotic disease caused by Sporothrix spp., which has impact on animal and human health. It manifests in humans by inoculation of the fungus after skin trauma, by scratching and/or biting animals. Diagnosis is clinical, epidemiological and laboratorial. Treatment is...

Full description

Bibliographic Details
Published in:Revista Médica de Minas Gerais
Main Authors: Carolina Rocha Lima Teixeira, Izadora Andressa Bezerra de Souza, Daniela Afonso Marquetotti, Giovanna Novaes Sampaio, Leilane Nascimento Alves, Milene Karoline Jeronimo, Raquel Virgínia Rocha Vilela, Roberta Dias Rodrigues Rocha, Ronize Andréia Ferreira
Format: Article
Language:English
Published: Associação Médica de Minas Gerais 2024-11-01
Subjects:
Online Access:https://rmmg.org/artigo/detalhes/4109
Description
Summary:Sporotrichosis is a neglected zoonotic disease caused by Sporothrix spp., which has impact on animal and human health. It manifests in humans by inoculation of the fungus after skin trauma, by scratching and/or biting animals. Diagnosis is clinical, epidemiological and laboratorial. Treatment is performed with azolic compounds, usually without complications. The present work aims to report a clinical case of occupational sporotrichosis with an atypical evolution, which is refractory to conventional treatment with itraconazole. A 25-year-old immunocompetent student of Veterinary Medicine from Belo Horizonte/ MG was scratched by a two-year-old feline positive for sporotrichosis. Seven days post-infection she presented with a pruritic, erythematous nodular lesion on her right arm. Fungal culture obtained from the lesion has shown the growth of Sporothrix spp. At thirty days, a localized ulcerated lesion developed, with purulent exudation. After a ten-week treatment with itraconazole, the localized cutaneous form evolved to an atypical picture of hypersensitivity reaction/immunoreactive cutaneous sporotrichosis. At nine months, the picture evolved to emesis, hyporexia, alopecia, headache, myalgia, hematokezia, laboratory changes in liver enzymes, and anemia. The evolution was atypical and prolonged, with features of therapeutic failure and drug toxicity reactions. After eleven months, the therapeutic regimen was revised and a new therapy with amphotericin B was initiated, until the resolution of the infection, and total recovery took place at 13 months. This report alerts physicians and health professionals to the occurrence of atypical manifestations of sporotrichosis, failure to conventional therapy, and drug toxicity, and suggests a discussion about this new facet of sporotrichosis.
ISSN:2238-3182